Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: A clinico-pathological study

Bone Marrow Transplantation

Volumn 20, Issue 1, 1997, Pages 83-85

  Lim, S H ^a   Coleman, S ^a   Bull, A ^a   O'Callaghan, U ^a   Evely, R ^a   Booth, M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Autologous; GVHD; GVL

Indexed keywords

ALPHA INTERFERON; CYCLOSPORIN A; CYTOSINE; ETOPOSIDE; IDARUBICIN;

ADULT; ARTICLE; AUTOLOGOUS MIXED LYMPHOCYTE REACTION; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SKIN BIOPSY; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030872860     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700845     Document Type: Article

References (7)

1. Hale G, Waldmann H. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplant for malignant diseases. Bone Marrow Transplant 1995; 13: 597-611.
2. Kolb HJ, Mitteruller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
3. Coleman S, Fisher J, Hoy T et al. MHC-dependent leukaemia-reactive T-lymphocytes in a patient with chronic myeloid leukaemia. Leukemia 1996; 10: 483-487.
4. Glazier A, Tutschka PJ, Farmer ER, Santos G. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983; 158: 1-8.
5. Kennedy MJ, Vogelsang GB, Beveridge RA et al. Phase I trial of intravenous cyclosporin to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1993; 11: 478-484.
6. Ratanatharathorn V, Uberti J, Karanes C et al. Phase I study of alpha-interferon augmentation of cyclosporin-induced graft versus host disease in recipients of autologous bone marrow transplantation. Bone Marrow Transplant 1994; 13: 625-630.
7. Carella AM, Gaozza E, Raffo MR et al. Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporin A. Leukemia 1991; 5: 517-521.